nf-core pipeline · nanopore, pacbio
nf-core/longraredisease
A long-read sequencing pipeline to detect and interpret structural variants in rare diseases and neurodevelopment.
What nf-core/longraredisease is
nf-core/longraredisease is a bioinformatics pipeline engineered for the detection and clinical interpretation of structural variants using long-read sequencing technologies, specifically Oxford Nanopore Technologies and PacBio platforms. It is primarily targeted at rare disease diagnostics and identifying pathogenic variants in patients with neurodevelopmental disorders.
The pipeline was developed within the nf-core framework with support from clinical scientists and researchers including Chipo Mashayamombe-Wolfgarten, Hannah Titheradge, Lorraine Hartles-Spencer, Professor Andrew Beggs, Friederike Hanssen, Ken Brewer, Nicolas Vannieuwkerke, and Maxime U Garcia. It addresses the challenge of resolving complex genomic variants in rare disease cohorts by combining consensus variant calling with clinical annotation and phenotype-driven ranking.
By incorporating pedigree relationships and clinical features codified as Human Phenotype Ontology terms, the workflow enables researchers and clinical diagnostic teams to triage genomic variants effectively and pinpoint candidate de novo or inherited alterations.
What the pipeline does
The pipeline processes long-read alignments provided in BAM format. Structural variants are detected across multiple callers—Sniffles, CuteSV, and SVIM—and merged into a high-confidence consensus set using JASMINE. Variant calls are phased across haplotypes using LongPhase. For family trios, the workflow carries out joint calling and identifies de novo mutations based on sample pedigree structures specified in the input metadata.
Once structural variants are identified, they undergo clinical annotation through AnnotSV integrated with disease databases. Phenotype-driven variant prioritization is then executed using SVANNA, which ranks candidates based on user-supplied Human Phenotype Ontology terms. In addition to core structural variant discovery, the workflow can optionally be configured to detect single nucleotide variants with Clair3 or DeepVariant, copy number variants via Spectre or HiFiCNV, short tandem repeats using Straglr, and DNA methylation patterns with Modkit.
Key facts
- Sequencing platforms
- Oxford Nanopore Technologies, PacBio
- Input format
- BAM files via a CSV samplesheet, reference FASTA
- Primary caller tools
- Sniffles, CuteSV, SVIM
- SV merging tool
- JASMINE
- Phasing tool
- LongPhase
- Clinical annotation tool
- AnnotSV
- Phenotype prioritization tool
- SVANNA
- Optional SNV callers
- Clair3, DeepVariant
- Optional CNV callers
- Spectre, HiFiCNV
- Optional STR caller
- Straglr
- Optional methylation tool
- Modkit
- Latest release
- 1.0.0 (2026-06-26)
What you can use it for
- Neurodevelopmental disorder diagnosis
- Identify structural variants and rank their clinical relevance in patients presenting with neurodevelopmental phenotypes.
- Trio-based de novo variant discovery
- Perform joint family analysis on parent-child trios to isolate de novo structural variations underlying rare genetic conditions.
- Phenotype-prioritised variant screening
- Score and rank genomic alterations against clinical manifestations using patient-specific Human Phenotype Ontology terms via SVANNA.
- Comprehensive long-read variant profiling
- Optionally evaluate single nucleotide variants, copy number changes, short tandem repeats, and base methylation in tandem with structural variants.
Run it here
The research agent runs nf-core/longraredisease with Nextflow on its own machine — up to 32 cores, 256 GiB of memory and 24 hours per run, which covers the test profile and real single-sample runs. It builds the samplesheet, checks it against the pipeline's schema and reads the results back. When a run is too big for one machine, it gives you the exact command for your own cluster instead.
Strengths and limits
Good at
- Constructs high-confidence structural variant sets by merging calls from Sniffles, CuteSV, and SVIM via JASMINE.
- Enables haplotype-aware variant resolution through integration with LongPhase.
- Directly incorporates clinical Human Phenotype Ontology terms to rank candidate structural variants using SVANNA.
- Offers flexible optional modules for detecting single nucleotide variants, copy number variations, short tandem repeats, and methylation.
Watch out for
- Requires long-read sequencing inputs from Oxford Nanopore or PacBio, excluding short-read data.
- Configuration parameters cannot be passed via custom configuration files using the -c option and must instead be supplied via the command line or a parameters file.
Questions
Can I run nf-core/longraredisease without my own cluster?
The research agent runs nf-core/longraredisease with Nextflow on its own machine — up to 32 cores, 256 GiB of memory and 24 hours per run, which covers the test profile and real single-sample runs. It builds the samplesheet, checks it against the pipeline's schema and reads the results back. When a run is too big for one machine, it gives you the exact command for your own cluster instead.
What licence is nf-core/longraredisease under?
MIT, like every nf-core pipeline.
Which sequencing technologies are compatible with this pipeline?
The pipeline accepts long-read sequencing data generated on either Oxford Nanopore Technologies or PacBio instruments.
How are clinical features passed to the workflow?
Clinical symptoms are supplied as semicolon-separated Human Phenotype Ontology (HPO) terms within the pipeline's input samplesheet.
Does the pipeline support family pedigree analyses?
Yes, it supports family-based trio analysis, joint variant calling, and the identification of de novo variants using family, maternal, and paternal identifiers defined in the samplesheet.
Can the pipeline identify variant types other than structural variants?
Yes, optional modules are available to detect single nucleotide variants using Clair3 or DeepVariant, copy number variants via Spectre or HiFiCNV, short tandem repeats using Straglr, and DNA methylation with Modkit.
How to cite it
10.5281/zenodo.20935122
Written from nf-core/longraredisease's own README. Statements citing a figure that does not appear there are removed before publication. Licence and running details come from our registry.